Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs PINK overlap: 41% of top holdings shared

Bottom line

How much do XLV and PINK overlap?

41% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 59.8% of XLV's assets and 40.1% of PINK's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVPINK
Weight overlap (top 25)41%
Shared holdings12
Weight in shared holdings59.8%40.1%
Total positions6554
Expense ratio0.08%0.51%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and PINK have in common

Holding% of XLV% of PINKOverlap
Eli Lilly & Co16.51%5.91%5.91%
Johnson & Johnson10.64%5.45%5.45%
AbbVie Inc7.74%4.52%4.52%
UnitedHealth Group Inc6.57%5.76%5.76%
Amgen Inc3.40%2.12%2.12%
Thermo Fisher Scientific Inc3.24%3.23%3.23%
Gilead Sciences Inc2.73%2.87%2.73%
CVS Health Corp2.30%2.01%2.01%
Vertex Pharmaceuticals Inc2.19%1.45%1.45%
Danaher Corp2.09%2.28%2.09%
Elevance Health Inc1.46%2.73%1.46%
Cardinal Health Inc0.97%1.78%0.97%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Merck & Co Inc — 5.52%
  2. Abbott Laboratories — 2.75%
  3. Intuitive Surgical Inc — 2.45%
  4. Pfizer Inc — 2.39%
  5. Bristol-Myers Squibb Co — 2.05%
  6. Stryker Corp — 1.89%
  7. Medtronic PLC — 1.75%
  8. McKesson Corp — 1.58%
  9. Cigna Group/The — 1.27%
  10. Boston Scientific Corp — 1.10%
  11. Regeneron Pharmaceuticals Inc — 1.08%
  12. HCA Healthcare Inc — 1.05%
  13. Cencora Inc — 0.96%

Only in PINK

  1. Purecycle Technologies Inc — 6.89%
  2. United Therapeutics Corp — 6.86%
  3. Novo Nordisk A/s — 6.75%
  4. Warby Parker Inc — 5.46%
  5. Jazz Pharmaceuticals Plc — 4.61%
  6. Biohaven Ltd — 4.32%
  7. Benitec Biopharma Inc — 3.75%
  8. Align Technology Inc — 3.14%
  9. 10x Genomics Inc — 3.13%
  10. Quest Diagnostics Inc — 2.94%
  11. Astrazeneca Plc — 1.81%
  12. Establishment Labs Holdings Inc — 1.45%
  13. Eyepoint Inc — 1.44%

Asset mix

Asset typeXLVPINK
Stocks99.7%99.6%
Cash & short-term funds0.3%0.4%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVPINK
US97.9%81.0%
DK—6.8%
VG—5.8%
IE2.1%4.7%
GB—1.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and PINK overlap?
About 41% by weight. 12 securities appear in both funds' top 25 holdings; they make up 59.8% of XLV's assets and 40.1% of PINK's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and PINK have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Johnson & Johnson, AbbVie Inc, Thermo Fisher Scientific Inc.
Should I own both XLV and PINK?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or PINK?
XLV is broader, with 65 positions versus 54 for PINK. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.